Skip to main content
logo
Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ: VRCA · Real-Time Price · USD
4.130
-0.010 (-0.24%)
Oct 8, 2026, 12:25 PM EDT - Market open

Verrica Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
30.3235.587.575.129.0312
Revenue Growth
106.21%370.22%47.66%-43.27%-24.73%-
Gross Profit
11.4323.28-7.01-15.92-3.89-3.93
Operating Income
-26.43-11.94-65.84-63.22-21.3-30.91
Net Income
-31.18-17.89-76.58-67-24.49-35.08
Earnings Per Share
-1.88-1.68-14.78-14.78-7.17-13.00
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
11.230.1546.3369.5534.2770.35
Total Debt
1.811.6345.9445.511.5343.41
Net Cash (Debt)
9.3928.520.3924.0432.7526.95
Net Cash Growth
-7211.79%-98.38%-26.60%21.53%-4.67%
Net Cash Per Share
0.572.680.085.309.599.96

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-13.35-17.63-60.93-38.58-18.65-27.58
Capital Expenditures
---0.03-0.36-0.3-0.88
Free Cash Flow
-13.35-17.63-60.95-38.94-18.95-28.47
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
37.68%65.44%-92.70%--43.08%-32.74%
Operating Margin
-87.18%-33.56%-870.16%-1233.84%-235.78%-257.57%
Pretax Margin
-102.84%-50.27%-1012.15%-1307.47%-271.11%-292.33%
Profit Margin
-102.84%-50.27%-1012.15%-1307.47%-271.11%-292.33%
FCF Margin
-44.02%-49.55%-805.63%-759.93%-209.83%-237.21%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
2.353.748.3860.0912.5121.01